This is an old revision of the document!
Robert Pless
Dr. Robert Pless, MD, MSc, is a Canadian epidemiologist and vaccine specialist based in Ottawa, Ontario.
Career and Affiliations
Health Canada
Pless has held multiple positions at Health Canada.1)
From May 2017 to March 2018, he served as a Manager at Marketed Biologicals, Biotechnology and Natural Health Products Bureau, Marketed Health Products Directorate.2)
Public Health Agency of Canada
Pless is formerly an ex-officio representative for the Biologics and Genetic Therapies Directorate at Health Canada on the National Advisory Committee on Immunization (NACI), serving at the time the group approved COVID-19 vaccines in Canada.3) Since September 2021, he is a member of the NACI High Consequence Infectious Disease Working Group.4)
1)
Robert Pless. LinkedIn. Retrieved April 21, 2022, from https://www.linkedin.com/in/robert-pless-aa200320/?originalSubdomain=ca
2)
Jordan, S. A., Jack, S. A., & Pless, R. P. (2018). Safety Surveillance of Dietary Supplements: Importance, Challenges, and New Horizons. Clinical Pharmacology & Therapeutics, 104(3), 432–434. https://doi.org/10.1002/cpt.1101
3)
National Advisory Committee on Immunization (NACI): Membership and representation. (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html
4)
Public Health Agency of Canada. (2022, February 9). COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2: NACI rapid response. Government of Canada. https://web.archive.org/web/20220422032902/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-covid-19-vaccination-timing-individuals-previously-infected-sars-cov-2.html